Profiel
Spencer W.
Farr is the founder of Vista Therapeutics, Inc. where he holds the title of President.
Dr. Farr is also the founder of Xenometrix, Inc., Molecular Toxicology, Inc...
.
Dr. Farr is also the founder of Xenometrix, Inc., Molecular Toxicology, Inc...
Actieve functies van Spencer W. Farr
| Bedrijven | Functie | Begin |
|---|---|---|
Vista Therapeutics, Inc.
 Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | Oprichter | 01-01-2007 |
Eerdere bekende functies van Spencer W. Farr
| Bedrijven | Functie | Einde |
|---|---|---|
| Molecular Toxicology, Inc. | Algemeen Directeur | - |
Xenometrix, Inc.
 Xenometrix, Inc. Medical SpecialtiesHealth Technology Xenometrix, Inc. operates as a biotechnology company with a proprietary gene profiling system that characterizes a cell's response when tested with compounds and other agents by the pattern of genes turned on and off in the cell. The company was founded by Spencer Farr and is headquartered in Boulder, CO. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Vista Therapeutics, Inc.
Vista Therapeutics, Inc. BiotechnologyHealth Technology Vista Therapeutics, Inc. develops nanotechnology for multiplex biomarker measurement. Its NanoBioSensor technology provides continuous, real-time measurement of multiple biomarkers simultaneously in any clinical setting. The firm's technology can be used to improve the quality of animal data in drug development. The company was founded by Spencer W. Farr and Charles M. Lieber in 2007 and is headquartered in Santa Fe, NM. | Health Technology |
Xenometrix, Inc.
Xenometrix, Inc. Medical SpecialtiesHealth Technology Xenometrix, Inc. operates as a biotechnology company with a proprietary gene profiling system that characterizes a cell's response when tested with compounds and other agents by the pattern of genes turned on and off in the cell. The company was founded by Spencer Farr and is headquartered in Boulder, CO. | Health Technology |
| Molecular Toxicology, Inc. |
